Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cell Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03249727
What this trial is testing

Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy

Who this might be right for
Immunity, InnateColorectal Cancer
ATGen Canada Inc 396
Early research (Phase 1)Study completedNCT05987696
What this trial is testing

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Who this might be right for
AML, AdultMinimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 2
Not applicableStudy completedNCT00824889
What this trial is testing

Exploratory Study of Natural Killer Cells in Human Skin

Who this might be right for
Atopic DermatitisContact DermatitisPsoriasis+3 more
Assistance Publique Hopitaux De Marseille 28
Testing effectiveness (Phase 2)Study completedNCT01181258
What this trial is testing

Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Masonic Cancer Center, University of Minnesota 16
Large-scale testing (Phase 3)UnknownNCT02631239
What this trial is testing

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Ruijin Hospital 256
Testing effectiveness (Phase 2)Ended earlyNCT00652899
What this trial is testing

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)UnknownNCT02080234
What this trial is testing

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 40
Early research (Phase 1)UnknownNCT02882659
What this trial is testing

Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Who this might be right for
Colorectal NeoplasmsHepatocellular CarcinomaNeoplasm Metastasis
FullHope Biomedical Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06674265
What this trial is testing

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children
Marzieh Ebrahimi 10
Early research (Phase 1)Looking for participantsNCT06751134
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, Refractory
Nanjing Children's Hospital 12
Early research (Phase 1)Active Not RecruitingNCT03774654
What this trial is testing

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Who this might be right for
Refractory B-Cell Non-Hodgkin LymphomaRefractory B-Cell Small Lymphocytic LymphomaRelapsed Adult ALL+2 more
Baylor College of Medicine 13
Very early researchUnknownNCT04209712
What this trial is testing

Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease

Who this might be right for
Acute Myeloid Leukemia
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China 6
Early research (Phase 1)Temporarily pausedNCT05887882
What this trial is testing

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Who this might be right for
Pediatric Brain TumorRecurrent Pediatric Brain TumorPediatric Neoplasm
Sabine Mueller, MD, PhD 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Not applicableStudy completedNCT03779399
What this trial is testing

Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor

Who this might be right for
Ovarian CancerBorderline Ovarian TumorsBenign Ovarian Tumor+1 more
Medical University of Lublin 60
Testing effectiveness (Phase 2)Looking for participantsNCT05503134
What this trial is testing

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Nationwide Children's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00394381
What this trial is testing

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome, High Grade
Singapore General Hospital 17
Early research (Phase 1)Study completedNCT02316964
What this trial is testing

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Sumithira Vasu 8
Early research (Phase 1)Study completedNCT02845999
What this trial is testing

Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab

Who this might be right for
Gastrointestinal Metastatic Cancer
Centre Hospitalier Universitaire de Besancon 9
Next Page